Karina Sultankulova: Smarter D-Dimer Strategies for Safe and Efficient DVT Exclusion
Karina Sultankulova, Clinical Director at American Medical Centers, shared on LinkedIn about a recent article by Menno V Huisman and Kenneth A Bauer, published in UpToDate, adding:
”In clinical practice, ruling out Deep Vein Thrombosis (DVT) using a fixed D-dimer cutoff of 500 ng/mL often leads to over-testing, especially in older adults where baseline levels naturally rise.
Modern, evidence-based strategies allow us to safely optimize efficiency without compromising patient safety:
1. Age-adjusted cutoff
For patients >50 years old with a low/moderate pretest probability, use the following validated formula:
Age (years) x 10 ng/mL
The evidence:
Data from a multicenter prospective study of 3,205 patients showed that this approach safely ruled out DVT without compression ultrasonography (CUS).
At 3 months, there were zero VTE events in patients who fell between the fixed 500 ng/mL and their higher age-adjusted limit.
The impact: In patients ≥75 yo, it tripled the number of people who could safely avoid unnecessary imaging (16% vs. 5% using the conventional cutoff), significantly increasing specificity.
2. Pretest probability (PTP)-Adjusted Cutoff
This strategy adjusts the D-dimer threshold based on clinical risk assessment (e.g., Wells Score):
Low PTP: DVT is excluded if D-dimer is <1000 ng/mL.
Moderate PTP: DVT is excluded if D-dimer is <500 ng/mL.
The Impact: Clinical studies show this reduces the overall need for ultrasound scans by 8% to 47%, maintaining an incredibly safe missed-thrombosis rate of less than 0.6% during follow-up.
Key takeaway:
Adopting adjusted D-dimer cutoffs reduces unnecessary diagnostic imaging, lowers healthcare costs, and spares elderly patients from redundant hospital stress – all while safely excluding thromboembolic events.”
Title: Clinical presentation and diagnosis of the nonpregnant adult with suspected deep vein thrombosis of the lower extremity
Authors: Menno V Huisman, Kenneth A Bauer
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 18:11Bharath Kumar V.։ Advancing Safer Anticoagulation for Cancer-Associated Thrombosis
-
Sep 22, 2026, 18:10Fatima Zahra: ASH Released New Guidelines on the Diagnosis of Iron Deficiency
-
Sep 22, 2026, 17:49Nirav Dhanesha: Targeting FXI for Safer Anticoagulation
-
Sep 22, 2026, 17:17Eric Lambert: Intravascular Imaging and the Future of Precision PCI
-
Sep 22, 2026, 16:45Claudiu Stoicescu: Are We Starting Cardiovascular Risk Assessment Too Late?
-
Sep 22, 2026, 16:35Complement – Coagulation Crosstalk in Thrombosis
-
Sep 22, 2026, 16:20Ila Bappa Ibrahim: Bringing Sickle Cell Innovation Closer to Communities
-
Sep 22, 2026, 16:02Ana Pedrero Gil: Peri-operative Management of Patients Undergoing Day Surgery
-
Sep 22, 2026, 15:27Zia Ullah: RBC-Derived Extracellular Vesicles as Potential Biomarkers of Thrombotic Risk in Dengue